Business Wire

Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, today announced a $65 million ...
Artnet

5 Surprising Facts About the Parthenon Marbles (Including the Existence of a Near-Perfect Replica in Nashville)

It’s hard not to be awestruck standing in front of the Parthenon marbles. The collection of sculptures adorned the famous archeological site, which was originally built as a temple to Athena in ...
Business Wire

Parthenon Therapeutics and ImaginAb Announce License and Supply Agreement to Advance New Class of Anti-Cancer Therapies’ Clinical Development Program

BOSTON & LOS ANGELES--(BUSINESS WIRE)--Parthenon Therapeutics, a precision oncology company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME), and ...